| |
| |
|
| Insider
Information: |
Karr Robert W |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,614 |
|
|
Indirect Shares
|
6,299 |
|
|
| Direct
Value |
$3,458 |
|
|
|
Indirect Value
|
$2,394 |
|
|
| Total
Shares |
15,913 |
|
|
| Total
Value |
$5,852 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aceragen, Inc |
ACGN |
Director |
2005-10-03 |
4,390 |
2013-09-16 |
6,299 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2008-12-31 |
5,224 |
2006-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACGN |
Aceragen, Inc |
Director |
– • – |
2013-09-16 |
4 |
B |
$1.76 |
$10,114 |
I/I |
5,750 |
6,299 |
2.1 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-12-31 |
4 |
A |
$16.84 |
$1,500 |
D/D |
89 |
5,224 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-10-01 |
4 |
A |
$19.02 |
$5,000 |
D/D |
263 |
5,135 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-09-30 |
4 |
A |
$19.02 |
$1,500 |
D/D |
79 |
4,872 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-07-01 |
4 |
A |
$14.35 |
$5,000 |
D/D |
348 |
4,794 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-06-30 |
4 |
A |
$14.35 |
$1,500 |
D/D |
105 |
4,445 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-04-01 |
4 |
A |
$16.08 |
$5,000 |
D/D |
311 |
4,341 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-03-31 |
4 |
A |
$16.08 |
$2,250 |
D/D |
140 |
4,030 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2008-01-01 |
4 |
A |
$14.35 |
$5,000 |
D/D |
348 |
3,890 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-12-31 |
4 |
A |
$14.35 |
$2,250 |
D/D |
157 |
3,541 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-10-01 |
4 |
A |
$16.28 |
$5,000 |
D/D |
307 |
3,384 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-09-30 |
4 |
A |
$16.28 |
$2,250 |
D/D |
138 |
3,077 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-07-01 |
4 |
A |
$16.19 |
$5,000 |
D/D |
309 |
2,939 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-04-01 |
4 |
A |
$20.40 |
$5,000 |
D/D |
245 |
2,630 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-02-28 |
4 |
A |
$21.21 |
$21,230 |
D/D |
1,000 |
2,385 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-01-01 |
4 |
A |
$17.84 |
$5,000 |
D/D |
280 |
1,385 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2006-10-01 |
4 |
A |
$9.24 |
$2,500 |
D/D |
271 |
1,105 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2006-07-01 |
4 |
A |
$9.10 |
$2,500 |
D/D |
275 |
834 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2006-04-01 |
4 |
A |
$10.92 |
$2,500 |
D/D |
229 |
560 |
|
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2005-10-03 |
4 |
B |
$0.57 |
$2,500 |
D/D |
4,390 |
4,390 |
2.31 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
